OBJECTIVES: To evaluate the association between percent body fat (%BF) and body mass index (BMI) among BMI-defined non-obese individuals between 40 and 69 years of age using a population-based Canadian sample. DATA AND METHODS: Cross-sectional data from the Canadian Health Measures Survey (2007 and 2009) was used to select all middle-aged individuals with BMI < 30 kg/m2 (n = 2,656). %BF was determined from anthropometric skinfolds and categorized according to sex-specific equations. Association of other anthropometry measures and metabolic markers were evaluated across different %BF categories. Significance of proportions was evaluated using chi-squared and Bonferroni-adjusted Wald test. Diagnostic performance measures of BMI-defined overweight categories compared to those defined by %BF were reported. RESULTS: The majority (69%) of the sample was %BF-defined overweight/obese, while 55% were BMI-defined overweight. BMI category was not concordant with %BF classification for 30% of the population. The greatest discordance between %BF and BMI was observed among %BF-defined overweight/obese women (32%). Sensitivity and specificity of BMI-defined overweight compared to %BF-defined overweight/obese were (58%, 94%) among females and (82%, 59%) among males respectively. According to the estimated negative predictive value, if an individual is categorized as BMI-defined non-obese, he/she has a 52% chance of being in the %BF-defined overweight/obese category. CONCLUSION: Middle-aged individuals classified as normal by BMI may be overweight/obese based on measures of %BF. These individuals may be at risk for chronic diseases, but would not be identified as such based on their BMI classification. Quantifying %BF in this group could inform targeted strategies for disease prevention.
OBJECTIVES: To evaluate the association between percent body fat (%BF) and body mass index (BMI) among BMI-defined non-obese individuals between 40 and 69 years of age using a population-based Canadian sample. DATA AND METHODS: Cross-sectional data from the Canadian Health Measures Survey (2007 and 2009) was used to select all middle-aged individuals with BMI &lt; 30 kg/m2 (n = 2,656). %BF was determined from anthropometric skinfolds and categorized according to sex-specific equations. Association of other anthropometry measures and metabolic markers were evaluated across different %BF categories. Significance of proportions was evaluated using chi-squared and Bonferroni-adjusted Wald test. Diagnostic performance measures of BMI-defined overweight categories compared to those defined by %BF were reported. RESULTS: The majority (69%) of the sample was %BF-defined overweight/obese, while 55% were BMI-defined overweight. BMI category was not concordant with %BF classification for 30% of the population. The greatest discordance between %BF and BMI was observed among %BF-defined overweight/obesewomen (32%). Sensitivity and specificity of BMI-defined overweight compared to %BF-defined overweight/obese were (58%, 94%) among females and (82%, 59%) among males respectively. According to the estimated negative predictive value, if an individual is categorized as BMI-defined non-obese, he/she has a 52% chance of being in the %BF-defined overweight/obese category. CONCLUSION: Middle-aged individuals classified as normal by BMI may be overweight/obese based on measures of %BF. These individuals may be at risk for chronic diseases, but would not be identified as such based on their BMI classification. Quantifying %BF in this group could inform targeted strategies for disease prevention.
Authors: Bret H Goodpaster; Shanthi Krishnaswami; Tamara B Harris; Andreas Katsiaras; Steven B Kritchevsky; Eleanor M Simonsick; Michael Nevitt; Paul Holvoet; Anne B Newman Journal: Arch Intern Med Date: 2005-04-11
Authors: A Romero-Corral; V K Somers; J Sierra-Johnson; R J Thomas; M L Collazo-Clavell; J Korinek; T G Allison; J A Batsis; F H Sert-Kuniyoshi; F Lopez-Jimenez Journal: Int J Obes (Lond) Date: 2008-02-19 Impact factor: 5.095
Authors: A H Kissebah; N Vydelingum; R Murray; D J Evans; A J Hartz; R K Kalkhoff; P W Adams Journal: J Clin Endocrinol Metab Date: 1982-02 Impact factor: 5.958
Authors: Kelsey H Collins; Walter Herzog; Graham Z MacDonald; Raylene A Reimer; Jaqueline L Rios; Ian C Smith; Ronald F Zernicke; David A Hart Journal: Front Physiol Date: 2018-02-23 Impact factor: 4.566
Authors: Reshma Aziz Merchant; Santhosh Seetharaman; Lydia Au; Michael Wai Kit Wong; Beatrix Ling Ling Wong; Li Feng Tan; Matthew Zhixuan Chen; Shu Ee Ng; John Tshon Yit Soong; Richard Jor Yeong Hui; Sing Cheer Kwek; John E Morley Journal: Front Endocrinol (Lausanne) Date: 2021-12-24 Impact factor: 5.555
Authors: Kelsey H Collins; Behnam Sharif; Raylene A Reimer; Claudia Sanmartin; Walter Herzog; Rick Chin; Deborah A Marshall Journal: BMC Obes Date: 2018-09-03